GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 89 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,986 | -13.2% | 25,573 | -1.5% | 0.00% | – |
| Q2 2023 | $50,647 | -29.9% | 25,973 | 0.0% | 0.00% | – |
| Q1 2023 | $72,205 | -17.3% | 25,973 | +2.7% | 0.00% | – |
| Q4 2022 | $87,285 | +47.9% | 25,300 | +11.0% | 0.00% | – |
| Q3 2022 | $59,000 | +18.0% | 22,800 | +10.1% | 0.00% | – |
| Q2 2022 | $50,000 | -26.5% | 20,700 | +26.2% | 0.00% | – |
| Q1 2022 | $68,000 | -64.0% | 16,400 | +11.6% | 0.00% | – |
| Q4 2021 | $189,000 | -50.1% | 14,700 | -58.1% | 0.00% | -100.0% |
| Q3 2021 | $379,000 | +77.1% | 35,050 | +49.8% | 0.00% | – |
| Q2 2021 | $214,000 | -4.5% | 23,400 | -1.7% | 0.00% | -100.0% |
| Q1 2021 | $224,000 | +194.7% | 23,800 | +24.0% | 0.00% | – |
| Q4 2020 | $76,000 | +123.5% | 19,200 | +51.8% | 0.00% | – |
| Q3 2020 | $34,000 | – | 12,647 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 3,561,150 | $6,125,178 | 3.26% |
| Redmile Group, LLC | 8,509,126 | $14,635,697 | 0.70% |
| Avidity Partners Management LP | 2,733,800 | $4,702,136 | 0.19% |
| Frazier Life Sciences Management, L.P. | 1,430,878 | $2,461,110 | 0.16% |
| Artia Global Partners LP | 95,170 | $163,692 | 0.07% |
| Worth Venture Partners, LLC | 43,772 | $75,288 | 0.04% |
| SkyOak Wealth, LLC | 60,875 | $104,705 | 0.03% |
| Point72 Asset Management, L.P. | 5,924,867 | $10,190,771 | 0.03% |
| CORNERCAP INVESTMENT COUNSEL INC | 76,811 | $132,115 | 0.02% |
| Houlihan Financial Resource Group, Ltd. | 20,000 | $38 | 0.02% |